Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer
Status:
Active, not recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of LY3023414 in treating the
participants type of cancer and to determine the types and severity of side effects caused by
treatment with LY3023414.